# Phase 2a Study of PBTZ169

> **NCT03334734** · PHASE2 · TERMINATED · sponsor: **Nearmedic Plus LLC** · enrollment: 16 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** PBTZ169
- **DRUG:** Isoniazid

## Key facts

- **NCT ID:** NCT03334734
- **Lead sponsor:** Nearmedic Plus LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12-16
- **Primary completion:** 2017-09-10
- **Final completion:** 2018-02-22
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Very slow enrollment
- **Last updated:** 2020-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03334734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03334734, "Phase 2a Study of PBTZ169". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03334734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*